Groupama has seen its healthcare business revenues grow over the first six months of the year and further discussed its decision, announced this week, to sell the business.
It cited the importance of significant scale required to compete in the highly competitive SME market and lack of desire to fund external growth. Groupama saw a 3% growth in private medical insurance (PMI) revenues and continued the trend from last year, although at half the previous rate. Health insurance brokers have voiced their extreme disappointment and concerns at the sale of the business which sees the market lose another provider. Commenting further on the decision to sell its healthcare arm to Simplyhealth, François-Xavier Boisseau, CEO of Groupama Insurances, explained: "...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
